Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Antimicrobial Effectiveness

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Housing mobility program effects on ambient fine particulate matter exposure and childhood asthma morbidity.

Annals of the American Thoracic Society·2026

Same author

Managing Renewed Food Avoidance Following an Allergic Reaction for Patients With Avoidant/Restrictive Food Intake Disorder.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026

Same author

Navigating Oral Food Challenges in Clinical Trials to Keep the Science Moving Forward.

Allergy·2026

Same author

Clinical outcomes in food allergy: Implications for patients, clinicians, and health systems.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026

Same author

When Medically Required Food Avoidance Goes Awry: A Conceptual Framework of ARFID as an Underrecognized Clinical Complication of Food Allergy.

The International journal of eating disorders·2026

Same author

Management of Gastrointestinal Symptoms During Oral Immunotherapy: Guidance from OUtMATCH Investigators.

The journal of allergy and clinical immunology. In practice·2026

Same journal

Impact of cognitive impairment and depression on asthma in older patients.

The journal of allergy and clinical immunology. In practice·2026

Same journal

Refractory Atopic Dermatitis Unmasking Mycosis Fungoides During Targeted Therapy.

The journal of allergy and clinical immunology. In practice·2026

Same journal

ASTHMA CONTROL BEFORE AND AFTER CHANGING GAS STOVES TO ELECTRIC STOVES.

The journal of allergy and clinical immunology. In practice·2026

Same journal

Multiplex Cytokine LTT Reveals Strong T Cell Responses to Multiple Drugs in NIDHR-Associated Multiple Drug Hypersensitivity.

The journal of allergy and clinical immunology. In practice·2026

Same journal

Allergic Fungal Rhinosinusitis: Distinct Clinical Features, Diagnostic Challenges, and Evolving Therapeutic Strategies.

The journal of allergy and clinical immunology. In practice·2026

Same journal

Effectiveness of treatment with tezepelumab in patients with severe asthma, smoking asthmatics and patients with severe Asthma and COPD: A real-world cohort study.

The journal of allergy and clinical immunology. In practice·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 9, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

Omalizumab Implementation in Practice: Lessons Learned From the OUtMATCH Study.

Brian P Vickery¹, J Andrew Bird², R Sharon Chinthrajah³

¹Department of Pediatrics, Emory University School of Medicine, Atlanta, Ga; Department of Pediatrics, Children's Healthcare of Atlanta, Atlanta, Ga.

The Journal of Allergy and Clinical Immunology. in Practice

|September 18, 2024

Summary

This summary is machine-generated.

Omalizumab is now approved for food allergy treatment, showing significant desensitization in a major trial. Further research is needed to optimize its use in clinical practice for better patient outcomes.

Keywords:

Anti-IgE Clinical trial Desensitization Food allergy Omalizumab Oral immunotherapy

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF

Published on: September 17, 2019

Related Experiment Videos

Last Updated: May 9, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF

Published on: September 17, 2019

Area of Science:

Immunology
Allergology
Clinical Trials

Background:

Food allergy is a growing global health concern.
Current treatments are limited, primarily focusing on avoidance.
Omalizumab represents a novel therapeutic approach.

Purpose of the Study:

To evaluate the efficacy and safety of omalizumab in treating food allergy.
To assess the potential for multi-allergen desensitization with omalizumab.
To provide perspectives on the clinical application of omalizumab for food allergy.

Main Methods:

The OUtMATCH trial was a landmark Phase 3 clinical study.
Participants received omalizumab or placebo.
Key endpoints included desensitization and tolerance to multiple food allergens.

Main Results:

The study met primary and secondary endpoints, demonstrating a large effect size for multi-allergen desensitization compared to placebo.
A subset of participants did not respond to treatment.
Tolerance to all three food allergens was less frequent than tolerance to single foods.

Conclusions:

Omalizumab shows promise for food allergy treatment, enabling multi-allergen desensitization.
Patient selection and management strategies require further investigation for optimal real-world application.
Ongoing research is crucial to address remaining questions and ensure effective translation into clinical practice.